menu
    • menu

    Company profile for NeoPhore

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We create novel small molecule immuno‑oncology therapeutics Our compounds target components of the MMR pathway that have been validated in both clinical and preclinical studies. These components are known to modulate neoantigen creation and diversity across numerous cancers.Drugs that are designed to spark cancer neoantigen creation and subsequently stimulate the immune system can improve outcomes for patients who do not be...
    We create novel small molecule immuno‑oncology therapeutics Our compounds target components of the MMR pathway that have been validated in both clinical and preclinical studies. These components are known to modulate neoantigen creation and diversity across numerous cancers.Drugs that are designed to spark cancer neoantigen creation and subsequently stimulate the immune system can improve outcomes for patients who do not benefit from the current generation of cancer immunotherapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeoPhoreunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT
    Telephone
    Telephone
    +44 0 330 128 9990
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neophore.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neophore-ltd/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Coulter Partners secures CEO Placement for NeoPhore
    Coulter Partners secures CEO Placement for NeoPhore

    22 Jan 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-01-23/coulter-partners-secures-ceo-placement-for-neophore

    PHARMAWEB
    22 Jan 2025
    Share Share
    NeoPhore appoints Michael Shih as Chief Executive Officer
    NeoPhore appoints Michael Shih as Chief Executive Officer

    16 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neophore-appoints-michael-shih-as-chief-executive-officer-302331551.html

    PR NEWSWIRE
    16 Dec 2024
    Share Share
    NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension
    NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension

    01 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neophore-raises-an-additional-9-6m-usd-12-2m-series-b-financing-extension-to-further-progress-drug-discovery-pipeline-302049679.html

    PR NEWSWIRE
    01 Feb 2024
    Share Share
    NeoPhore signs research collaboration with The Institute of Cancer Research
    NeoPhore signs research collaboration with The Institute of Cancer Research

    18 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/neophore-signs-research-collaboration-with-the-institute-of-cancer-research-london-301799116.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search